aDivision of Microbiology, Department of Pathobiology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
bMolecular Biology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran
cFood Microbiology Research Center, Tehran University of Medical Sciences, Tehran, Iran
dDepartment of Microbiology and Immunology, Medical School, Alborz University of Medical Sciences, Karaj, Iran
eDepartment of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
Copyright ©2017, Korea Centers for Disease Control and Prevention
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
CONFLICTS OF INTEREST
No potential conflict of interest relevant to this article was reported.
Gene targeted | Primer | Sequence | Product size (bp) | Reference | Tm |
---|---|---|---|---|---|
set1A | ShET-1A | F: 5′-TCACGCTACCATCAAAGA-3′ | 309 | [15] | 55 |
R: 5′-TATCCCCCTTTGGTGGTA-3′ | |||||
set1B | ShET-1B | F: 5′-GTGAACCTGCTGCCGATATC-3′ | 147 | [15] | 55 |
R: 5′-ATTTGTGGATAAAAATGACG-3′ | |||||
sat | Sat1 | F: 5′-ACTGGCGGACTCATGCTGT-3′ | 387 | [17] | 55 |
R: 5′-AACCCTGTAAGAAGACTGAGC-3′ | |||||
ial | Ial1 | F;CTGGATGGTATGGTGAGG | 320 | [15] | 58 |
R;GGAGGCCAACAATTATTTCC | |||||
ipaH | Shig1 | F: 5′-TGGAAAAACTCAGTGCCTCT-3′ | 423 | [16] | 58 |
R: 5′-CCAGTCCGTAAATTCATTCT-3′ | |||||
virA | virA | F-CTGCATTCTGGCAATCTCTTCACATC | 215 | [15] | 58 |
R-TGATGAGCTAACTTCGTAAGCCCTCC | |||||
Stx | Stx1 | F: 5′-CAGTTAATGTGGTTGCGAAG-3′ | 895 | [15] | 60 |
R: 5′-CTGCTAATAGTTCTGCGCATC-3′ | |||||
sen | ShET2 | F: 5′-ATGTGCCTGCTATTATTTAT-3′ | 799 | [15] | 60 |
R: 5′-CATAATAATAAGCGGTCAGC-3′ | |||||
ipaBCD | ipaBCD | F: 5′-GCTATAGCAGTGACATGG-3′ | 612 | [18] | 60 |
R: 5′-ACGAGTTCGAAGCACTC-3′ |
Values are presented as number (%). NA, not available.
Combination of genes: I: ipaBCD + ipaH + virA; II: ipaBCD + ipaH + virA + iaI; III: ipaBCD + ipaH + virA + ial + sat; IV: ipaBCD + ipaH + virA+ ial + sat + sen; V: ipaBCD + ial + ipaH + virA + setlA + setlB + sen + sat.
p < 0.05 was considered statistically significant.
Virulence gene | Hospitalization | OR (CI) | p-value | Bloody diarrhea | OR (CI) | p-value | |||
---|---|---|---|---|---|---|---|---|---|
Positive | Negative | Positive | Negative | ||||||
SET.1A | Positive | 3 (30.0) | 15 (23.8) | 0.7 (0.16–3.1) | NS | 16 (88.9) | 20 (36.4) | 3.1 (2.97–6.1) | 0.001** |
Negative | 7 (70.0) | 48 (76.2) | 2 (11.1) | 35 (63.6) | |||||
SET.1B | Positive | 3 (30.0) | 15 (23.8) | 0.7 (0.16–3.1) | NS | 16 (88.9) | 20 (36.4) | 3.1 (2.97–6.1) | 0.001** |
Negative | 7 (70.0) | 48 (76.2) | 2 (11.1) | 35 (63.6) | |||||
SEN | Positive | 10 (100) | 24 (38.1) | 1.1 (0.6–2.1) | 0.001** | 24 (70.6) | 12 (30.8) | 3.2 (1.9–7.2) | 0.001** |
Negative | 0 | 39 (61.9) | 10 (29.4) | 27 (69.2) | |||||
SAT | Positive | 3 (30.0) | 18 (28.6) | 0.9 (0.6–1.4) | NS | 18 (85.7) | 18 (34.6) | NR | NR |
Negative | 7 (70.0) | 45 (71.4) | 3 (14.3) | 34 (65.4) |
High Rates of Antimicrobial Resistance and Virulence Gene Distribution Among Shigella spp. Isolated from Pediatric Patients in Tehran, Iran
Gene targeted | Primer | Sequence | Product size (bp) | Reference | Tm |
---|---|---|---|---|---|
set1A | ShET-1A | F: 5′-TCACGCTACCATCAAAGA-3′ | 309 | [ | 55 |
R: 5′-TATCCCCCTTTGGTGGTA-3′ | |||||
set1B | ShET-1B | F: 5′-GTGAACCTGCTGCCGATATC-3′ | 147 | [ | 55 |
R: 5′-ATTTGTGGATAAAAATGACG-3′ | |||||
sat | Sat1 | F: 5′-ACTGGCGGACTCATGCTGT-3′ | 387 | [ | 55 |
R: 5′-AACCCTGTAAGAAGACTGAGC-3′ | |||||
ial | Ial1 | F;CTGGATGGTATGGTGAGG | 320 | [ | 58 |
R;GGAGGCCAACAATTATTTCC | |||||
ipaH | Shig1 | F: 5′-TGGAAAAACTCAGTGCCTCT-3′ | 423 | [ | 58 |
R: 5′-CCAGTCCGTAAATTCATTCT-3′ | |||||
virA | virA | F-CTGCATTCTGGCAATCTCTTCACATC | 215 | [ | 58 |
R-TGATGAGCTAACTTCGTAAGCCCTCC | |||||
Stx | Stx1 | F: 5′-CAGTTAATGTGGTTGCGAAG-3′ | 895 | [ | 60 |
R: 5′-CTGCTAATAGTTCTGCGCATC-3′ | |||||
sen | ShET2 | F: 5′-ATGTGCCTGCTATTATTTAT-3′ | 799 | [ | 60 |
R: 5′-CATAATAATAAGCGGTCAGC-3′ | |||||
ipaBCD | ipaBCD | F: 5′-GCTATAGCAGTGACATGG-3′ | 612 | [ | 60 |
R: 5′-ACGAGTTCGAAGCACTC-3′ |
Virulence gene (Shigella species) | Isolates | Isolates with a combination of genes | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| |||||||||||||
ipaBCD | VirA | sen | set1A | set1B | ipaH | ial | Stx | sat | I | II | III | IV | V | |
S. sonnei (n = 40) | 40 (100) | 40 (100) | 19 (47.5) | 0 (0) | 0 (0) | 40 (100) | 31 (77.5) | 0 (0) | 0 (0) | 40 (100) | 31 (77.5) | 0 (0) | 0 (0) | 0 (0) |
| ||||||||||||||
S. flexneri (n = 33) | 33 (100) | 33 (100) | 15 (45.5) | 18 (54.5) | 18 (54.5) | 33 (100) | 25 (75.7) | 0 (0) | 21 (63.6) | 33 (100) | 25 (75.7) | 19 (57.6) | 10 (30.3) | 5 (15.2) |
| ||||||||||||||
1a (n = 11) | 11 (100) | 11 (100) | 5 (45.5) | 0 (0) | 0 (0) | 11 (100) | 9 (81.8) | 0 (0) | 5 (45.4) | 11 (100) | 9 (81.9) | 4 (36.3) | 1 (9.0) | 0 (0) |
| ||||||||||||||
IIa (n = 22) | 22 (100) | 22 (100) | 10 (45.4) | 18 (81.8) | 18 (81.8) | 22 (100) | 16 (72.7) | 0 (0) | 16 (72.7) | 22 (100) | 16 (72.7) | 15 (68.1) | 9 (40.9) | 5 (22.7) |
| ||||||||||||||
S. flexneri vs. S. sonnei (p-value) | NA | NA | < 0.862 | < 0.000 | < 0.000 | NA | < 0.464 | NA | < 0.000 | NA | NA | NA | NA | NA |
| ||||||||||||||
S. boydii (n = 1) | 1 (100) | 1 (100) | 0 (0) | 0 (0) | 0 (0) | 1 (100) | 0 (0) | 0 (0) | 0 (0) | 1 (100) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
| ||||||||||||||
S. dysenteriae (n = 1) | 1 (100) | 1 (100) | 0 (0) | 0 (0) | 0 (0) | 1 (100) | 0 (0) | 1 (100) | 0 (0) | 1 (100) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
| ||||||||||||||
Total | 75 (100) | 75 (100) | 34 (45.4) | 18 (24) | 18 (24) | 75 (100) | 56 (74.7) | 1 (1.4) | 21 (28) | 75 (100) | 53 (74.7) | 19 (25.4) | 10 (13.4) | 5 (6.7) |
Virulence gene | Hospitalization | OR (CI) | p-value | Bloody diarrhea | OR (CI) | p-value | |||
---|---|---|---|---|---|---|---|---|---|
Positive | Negative | Positive | Negative | ||||||
SET.1A | Positive | 3 (30.0) | 15 (23.8) | 0.7 (0.16–3.1) | NS | 16 (88.9) | 20 (36.4) | 3.1 (2.97–6.1) | 0.001 |
Negative | 7 (70.0) | 48 (76.2) | 2 (11.1) | 35 (63.6) | |||||
SET.1B | Positive | 3 (30.0) | 15 (23.8) | 0.7 (0.16–3.1) | NS | 16 (88.9) | 20 (36.4) | 3.1 (2.97–6.1) | 0.001 |
Negative | 7 (70.0) | 48 (76.2) | 2 (11.1) | 35 (63.6) | |||||
SEN | Positive | 10 (100) | 24 (38.1) | 1.1 (0.6–2.1) | 0.001 | 24 (70.6) | 12 (30.8) | 3.2 (1.9–7.2) | 0.001 |
Negative | 0 | 39 (61.9) | 10 (29.4) | 27 (69.2) | |||||
SAT | Positive | 3 (30.0) | 18 (28.6) | 0.9 (0.6–1.4) | NS | 18 (85.7) | 18 (34.6) | NR | NR |
Negative | 7 (70.0) | 45 (71.4) | 3 (14.3) | 34 (65.4) |
Values are presented as number (%). NA, not available. Combination of genes: I:
Values are presented as number (%). OR, odds ratio; CI, confidence interval; NS, not significant; NR, not reported. Analyzed by Fisher’s exact test; significant difference.